Mario Fernández-Ruiz

68PUBLICATIONS
134CO-AUTHORS
Medical bacteriologyLegal institutions (incl. courts and justice systems)Cancer therapy (excl. chemotherapy and radiation therapy)Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Aug 19, 2026
Epidemiology and Risk Factors for Infection in Multiple Myeloma Patients Treated With Bispecific Antibodies.

|Aug 12, 2026
Infectious Complications in Living Donation Versus Donation After Brain Death Kidney Transplantation.

|Mar 11, 2026
Randomized double-blind clinical trial evaluating the effectiveness and safety of secondary prophylaxis with oral vancomycin versus placebo in the prevention of recurrence of clostridioides difficile infection in patients receiving systemic antibiotic therapy (PREVAN trial).

Rafael San-Juan, Julia Origüen, Mario Fernández-Ruiz

|Feb 27, 2026
Clinical Presentation, Risk Factors and Outcome of Non-Tuberculous Mycobacteria Infection in Hematopoietic Stem-Cell Transplantation: A Multinational Case-Control Study.

Mario Fernández-Ruiz, Jose Tiago Silva, Peggy L Carver

|Feb 20, 2026
Rezafungin for Salvage or Consolidation Therapy of Invasive Fungal Disease: Experience in Real-World Clinical Practice.

Jorge Boán, Eduardo Aparicio-Minguijón, Mario Fernández-Ruiz

|Dec 24, 2025
The Unnoticed Threat: Clinical Characteristics, Risk Factors, and Outcome of Mucormycosis in Solid Organ Transplantation.

Jorge Boán, Mario Fernández-Ruiz, Eduardo Aparicio-Minguijón

Pageof 12

Frequent Collaborators

38 joint publications

José María Aguado

36 joint publications

Francisco López-Medrano

25 joint publications

Rafael San-Juan

17 joint publications

Isabel Rodríguez-Goncer